OBJECTIVE: The aim of this study was to determine the utility of oral fluids for assessment of coronary and cardiovascular (CV) health. STUDY DESIGN: Twenty-nine patients with preexisting CV disease underwent an invasive cardiac procedure (alcohol septal ablation or percutaneous coronary intervention) and provided unstimulated whole saliva (UWS), sublingual swabs (LS), gingival swabs (GS) and serum at 0, 8, 16, 24, and 48 hours. Concentrations of 13 relevant biomarkers were determined and correlated with levels in serum and the oral fluids. RESULTS: Concentrations of the majority of biomarkers were higher in UWS than in LS and GS. Coronary and CV disease biomarkers in UWS correlated better with serum than with LS and GS based on group status and measures of time effect. Seven biomarkers demonstrated time effect changes consistent with serum biomarkers, including C-reactive protein and troponin I. CONCLUSIONS: Changes in serum biomarker profiles are reflected in oral fluids suggesting that oral fluid biomarkers could aid in the assessment of cardiac ischemia/necrosis.
OBJECTIVE: The aim of this study was to determine the utility of oral fluids for assessment of coronary and cardiovascular (CV) health. STUDY DESIGN: Twenty-nine patients with preexisting CV disease underwent an invasive cardiac procedure (alcohol septal ablation or percutaneous coronary intervention) and provided unstimulated whole saliva (UWS), sublingual swabs (LS), gingival swabs (GS) and serum at 0, 8, 16, 24, and 48 hours. Concentrations of 13 relevant biomarkers were determined and correlated with levels in serum and the oral fluids. RESULTS: Concentrations of the majority of biomarkers were higher in UWS than in LS and GS. Coronary and CV disease biomarkers in UWS correlated better with serum than with LS and GS based on group status and measures of time effect. Seven biomarkers demonstrated time effect changes consistent with serum biomarkers, including C-reactive protein and troponin I. CONCLUSIONS: Changes in serum biomarker profiles are reflected in oral fluids suggesting that oral fluid biomarkers could aid in the assessment of cardiac ischemia/necrosis.
Authors: Sricharan Bandhakavi; Susan K Van Riper; Pierre N Tawfik; Matthew D Stone; Tufia Haddad; Nelson L Rhodus; John V Carlis; Timothy J Griffin Journal: J Proteome Res Date: 2011-01-14 Impact factor: 4.466
Authors: Leslie R Halpern; Malcolm L Shealer; Rian Cho; Elizabeth B McMichael; Joseph Rogers; Daphne Ferguson-Young; Charles P Mouton; Mohammad Tabatabai; Janet Southerland; Pandu Gangula Journal: J Natl Med Assoc Date: 2017-09-18 Impact factor: 1.798
Authors: C S Miller; J D Foley; P N Floriano; N Christodoulides; J L Ebersole; C L Campbell; A L Bailey; B G Rose; D F Kinane; M J Novak; J T McDevitt; X Ding; R J Kryscio Journal: J Dent Res Date: 2014-05-30 Impact factor: 6.116
Authors: R S Redman; G S Kerr; J B Payne; T R Mikuls; J Huang; H R Sayles; K L Becker; E S Nylén Journal: Biotech Histochem Date: 2016 Impact factor: 1.718
Authors: Kenji O Mfuh; Samuel Tassi Yunga; Livo F Esemu; Obase Ngemani Bekindaka; Jessica Yonga; Jean Claude Djontu; Calixt D Mbakop; Diane W Taylor; Vivek R Nerurkar; Rose G F Leke Journal: Malar J Date: 2017-10-27 Impact factor: 2.979